162 related articles for article (PubMed ID: 15517326)
1. Does tibolone affect serum leptin levels and body weight in postmenopausal women?
Gol M; Ozsener S; Sendag F; Uretmen S; Oztekin K; Tanyalcin T; Bilgin O
Arch Gynecol Obstet; 2005 Jul; 272(2):127-30. PubMed ID: 15517326
[TBL] [Abstract][Full Text] [Related]
2. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.
Lambrinoudaki IV; Christodoulakos GE; Panoulis CP; Rizos DA; Dendrinos SG; Liakakos T; Augoulea AD; Creatsas GC
Maturitas; 2004 Jun; 48(2):107-13. PubMed ID: 15172084
[TBL] [Abstract][Full Text] [Related]
3. Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene.
Tommaselli GA; Di Carlo C; Di Spiezio Sardo A; Bifulco G; Cirillo D; Guida M; Capasso R; Nappi C
Menopause; 2006; 13(4):660-8. PubMed ID: 16837888
[TBL] [Abstract][Full Text] [Related]
4. Effects of hormone therapy and tibolone on body composition and serum leptin levels in postmenopausal women.
Dedeoğlu EN; Erenus M; Yörük P
Fertil Steril; 2009 Feb; 91(2):425-31. PubMed ID: 18249383
[TBL] [Abstract][Full Text] [Related]
5. Serum leptin levels and body weight in postmenopausal women under transdermal hormone replacement therapy.
Salbach B; Nawroth PP; Kübler W; von Holst Th; Salbach PB
Eur J Med Res; 2000 Feb; 5(2):63-6. PubMed ID: 10720565
[TBL] [Abstract][Full Text] [Related]
6. [Circulating leptin doesn not change in postmenopausal women receiving replacement therapy with tibolone].
Basurto L; Galván R; Ochoa R; Fonseca E; Zárate A
Ginecol Obstet Mex; 2000 Oct; 68():416-9. PubMed ID: 11138402
[TBL] [Abstract][Full Text] [Related]
7. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.
Odmark IS; Carlström K; Jonsson B; Jonasson AF
Maturitas; 2006 Jan; 53(1):89-96. PubMed ID: 15964160
[TBL] [Abstract][Full Text] [Related]
8. Effects of tibolone on body composition in postmenopausal women: a 1-year follow up study.
Boyanov MA; Shinkov AD
Maturitas; 2005 Aug; 51(4):363-9. PubMed ID: 16039409
[TBL] [Abstract][Full Text] [Related]
9. Short-term effects of hormone therapy on serum C-reactive protein levels in postmenopausal women.
Kiran H; Kiran G
Arch Gynecol Obstet; 2006 Apr; 274(1):9-12. PubMed ID: 16369811
[TBL] [Abstract][Full Text] [Related]
10. Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene.
Lambrinoudaki IV; Christodoulakos GE; Economou EV; Vlachou SA; Panoulis CP; Alexandrou AP; Kouskouni EE; Creatsas GC
Maturitas; 2008 Jan; 59(1):62-71. PubMed ID: 18164562
[TBL] [Abstract][Full Text] [Related]
11. Serum leptin concentrations in pre- and postmenopausal women on sex hormone therapy.
Bednarek-Tupikowska G; Filus A; Kuliczkowska-Płaksej J; Tupikowski K; Bohdanowicz-Pawlak A; Milewicz A
Gynecol Endocrinol; 2006 Apr; 22(4):207-12. PubMed ID: 16723307
[TBL] [Abstract][Full Text] [Related]
12. Relationship of serum leptin with age, body weight, body mass index, and bone mineral density in healthy mainland Chinese women.
Zhong N; Wu XP; Xu ZR; Wang AH; Luo XH; Cao XZ; Xie H; Shan PF; Liao EY
Clin Chim Acta; 2005 Jan; 351(1-2):161-8. PubMed ID: 15563886
[TBL] [Abstract][Full Text] [Related]
13. Effects of tibolone on endogenous nitric oxide (nitrite/nitrate levels) in postmenopausal women.
Akgül C; Canbaz M; Vural P
Int J Fertil Womens Med; 2002; 47(1):13-7. PubMed ID: 11900269
[TBL] [Abstract][Full Text] [Related]
14. Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer.
Dimitrakakis C; Keramopoulos D; Vourli G; Gaki V; Bredakis N; Keramopoulos A
Climacteric; 2005 Dec; 8(4):342-51. PubMed ID: 16390769
[TBL] [Abstract][Full Text] [Related]
15. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
Christodoulakos G; Lambrinoudaki I; Panoulis C; Sioulas V; Rizos D; Caramalis G; Botsis D; Creatsas G
Maturitas; 2005 Apr; 50(4):321-30. PubMed ID: 15780533
[TBL] [Abstract][Full Text] [Related]
16. Serum leptin levels in patients with premenstrual syndrome treated with GnRH analogues alone and in association with tibolone.
Tommaselli GA; Di Carlo C; Bifulco G; Di Spiezio Sardo A; Pellicano M; Nappi C
Clin Endocrinol (Oxf); 2003 Dec; 59(6):716-22. PubMed ID: 14974912
[TBL] [Abstract][Full Text] [Related]
17. [Effect of hormone replacement with tibolone on plasma insulin and blood glucose in postmenopause].
Saucedo RP; Basurto L; Fonseca E; Zárate A
Ginecol Obstet Mex; 2001 Aug; 69():301-3. PubMed ID: 11599314
[TBL] [Abstract][Full Text] [Related]
18. Effects of menopause and tibolone on antioxidants in postmenopausal women.
Vural P; Akgül C; Canbaz M
Ann Clin Biochem; 2005 May; 42(Pt 3):220-3. PubMed ID: 15949158
[TBL] [Abstract][Full Text] [Related]
19. Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study.
Castelo-Branco C; Palacios S; Vázquez F; Villero J; Ferrer J; Ascaso C; Balasch J
Fertil Steril; 2007 Aug; 88(2):383-9. PubMed ID: 17561009
[TBL] [Abstract][Full Text] [Related]
20. The influence of tibolone upon serum leptin levels in post-menopausal women.
Panidis DK; Rousso DH; Kourtis AI; Stergiopoulos KN; Mavromatidis GA; Katsikis IK
Eur J Obstet Gynecol Reprod Biol; 2001 May; 96(1):85-7. PubMed ID: 11311767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
